Cargando…

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). This study covered 60 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gang, Ji, Zhong-He, Yu, Yang, Li, Xin-Bao, Zhang, Yan-Bin, Peng, Kai-Wen, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690772/
https://www.ncbi.nlm.nih.gov/pubmed/29137079
http://dx.doi.org/10.1097/MD.0000000000008573
_version_ 1783279678925045760
author Liu, Gang
Ji, Zhong-He
Yu, Yang
Li, Xin-Bao
Zhang, Yan-Bin
Peng, Kai-Wen
Li, Yan
author_facet Liu, Gang
Ji, Zhong-He
Yu, Yang
Li, Xin-Bao
Zhang, Yan-Bin
Peng, Kai-Wen
Li, Yan
author_sort Liu, Gang
collection PubMed
description This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated. There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P < .05) in the study group than the control group. The peak value of serum Mb levels (426.65 ± 108.386 μg/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group. Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.
format Online
Article
Text
id pubmed-5690772
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-56907722017-11-28 Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study Liu, Gang Ji, Zhong-He Yu, Yang Li, Xin-Bao Zhang, Yan-Bin Peng, Kai-Wen Li, Yan Medicine (Baltimore) 7100 This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated. There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P < .05) in the study group than the control group. The peak value of serum Mb levels (426.65 ± 108.386 μg/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group. Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages. Wolters Kluwer Health 2017-11-10 /pmc/articles/PMC5690772/ /pubmed/29137079 http://dx.doi.org/10.1097/MD.0000000000008573 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 7100
Liu, Gang
Ji, Zhong-He
Yu, Yang
Li, Xin-Bao
Zhang, Yan-Bin
Peng, Kai-Wen
Li, Yan
Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title_full Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title_fullStr Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title_full_unstemmed Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title_short Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study
title_sort treatment of hypermyoglobinemia after crs + hipec for patients with peritoneal carcinomatosis: a retrospective comparative study
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690772/
https://www.ncbi.nlm.nih.gov/pubmed/29137079
http://dx.doi.org/10.1097/MD.0000000000008573
work_keys_str_mv AT liugang treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT jizhonghe treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT yuyang treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT lixinbao treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT zhangyanbin treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT pengkaiwen treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy
AT liyan treatmentofhypermyoglobinemiaaftercrshipecforpatientswithperitonealcarcinomatosisaretrospectivecomparativestudy